My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1144

    1.

    Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.

    Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N.

    Diabetes. 2001 Aug;50(8):1844-50.PMID: 11473047 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.

    Henriksen JE, Levin K, Thye-Rønn P, Alford F, Hother-Nielsen O, Holst JJ, Beck-Nielsen H.

    Diabetes. 2000 Jul;49(7):1209-18.PMID: 10909980 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Metabolic impact of a family history of Type 2 diabetes. Results from a European multicentre study (EGIR).

    Vaag A, Lehtovirta M, Thye-Rönn P, Groop L; European Group of Insulin Resistance.

    Diabet Med. 2001 Jul;18(7):533-40.PMID: 11553181 [PubMed - indexed for MEDLINE]Related articles

    4.

    Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.

    Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki-Järvinen H.

    Gastroenterology. 2008 Jul;135(1):122-30. Epub 2008 Mar 21.PMID: 18474251 [PubMed - indexed for MEDLINE]Related articles

    5.

    Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes.

    Meneilly GS, Elliott T.

    Diabetes Care. 1999 Jan;22(1):112-8.PMID: 10333911 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Assessment of hepatic insulin action in obese type 2 diabetic patients.

    Staehr P, Hother-Nielsen O, Levin K, Holst JJ, Beck-Nielsen H.

    Diabetes. 2001 Jun;50(6):1363-70.PMID: 11375337 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms.

    Bugianesi E, Gastaldelli A, Vanni E, Gambino R, Cassader M, Baldi S, Ponti V, Pagano G, Ferrannini E, Rizzetto M.

    Diabetologia. 2005 Apr;48(4):634-42. Epub 2005 Mar 4.PMID: 15747110 [PubMed - indexed for MEDLINE]Related articles

    8.

    Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.

    Halberstam M, Cohen N, Shlimovich P, Rossetti L, Shamoon H.

    Diabetes. 1996 May;45(5):659-66. Erratum in: Diabetes 1996 Sep;45(9):1285. PMID: 8621019 [PubMed - indexed for MEDLINE]Related articles

    9.

    In vivo glucose metabolism in obese and type II diabetic subjects with or without hypertension.

    Bonora E, Bonadonna RC, Del Prato S, Gulli G, Solini A, Matsuda M, DeFronzo RA.

    Diabetes. 1993 May;42(5):764-72.PMID: 8482434 [PubMed - indexed for MEDLINE]Related articles

    10.

    Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity.

    Bugianesi E, Pagotto U, Manini R, Vanni E, Gastaldelli A, de Iasio R, Gentilcore E, Natale S, Cassader M, Rizzetto M, Pasquali R, Marchesini G.

    J Clin Endocrinol Metab. 2005 Jun;90(6):3498-504. Epub 2005 Mar 29.PMID: 15797948 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: is cellular insulin resistance a secondary phenomenon?

    Eriksson JW, Smith U, Waagstein F, Wysocki M, Jansson PA.

    Diabetes. 1999 Aug;48(8):1572-8.PMID: 10426375 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Acute hyperinsulinaemia decreases cholesterol synthesis less in subjects with non-insulin-dependent diabetes mellitus than in non-diabetic subjects.

    Naoumova RP, Cummings MH, Watts GF, Rendell NB, Taylor GW, Sönksen PH, Thompson GR.

    Eur J Clin Invest. 1996 Apr;26(4):332-40.PMID: 8732493 [PubMed - indexed for MEDLINE]Related articles

    13.

    Whole-body glucose metabolism in obese patients with type 2 diabetes mellitus: the impact of hypertension and strict blood glucose control.

    Vestergaard H, Parving HH, Hansen L, Pedersen O.

    Diabet Med. 1995 Feb;12(2):156-63.PMID: 7743763 [PubMed - indexed for MEDLINE]Related articles

    14.

    Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.

    Vaag A, Alford F, Henriksen FL, Christopher M, Beck-Nielsen H.

    Diabetologia. 1995 Mar;38(3):326-36.PMID: 7758880 [PubMed - indexed for MEDLINE]Related articles

    15.

    Chronic physiologic hyperinsulinemia impairs suppression of plasma free fatty acids and increases de novo lipogenesis but does not cause dyslipidemia in conscious normal rats.

    Koopmans SJ, Kushwaha RS, DeFronzo RA.

    Metabolism. 1999 Mar;48(3):330-7.PMID: 10094109 [PubMed - indexed for MEDLINE]Related articles

    16.

    Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.

    Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD.

    J Clin Invest. 1996 Jun 1;97(11):2601-10.PMID: 8647954 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Glycemic control determines hepatic and peripheral glucose effectiveness in type 2 diabetic subjects.

    Hawkins M, Gabriely I, Wozniak R, Reddy K, Rossetti L, Shamoon H.

    Diabetes. 2002 Jul;51(7):2179-89.PMID: 12086948 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes.

    Bajaj M, Suraamornkul S, Pratipanawatr T, Hardies LJ, Pratipanawatr W, Glass L, Cersosimo E, Miyazaki Y, DeFronzo RA.

    Diabetes. 2003 Jun;52(6):1364-70.PMID: 12765945 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Glucose utilization and production in patients with maturity-onset diabetes of the young caused by a mutation of the hepatocyte nuclear factor-1alpha gene.

    Surmely JF, Guenat E, Philippe J, Dussoix P, Schneiter P, Temler E, Vaxillaire M, Froguel P, Jéquier E, Tappy L.

    Diabetes. 1998 Sep;47(9):1459-63.PMID: 9726235 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents.

    Deivanayagam S, Mohammed BS, Vitola BE, Naguib GH, Keshen TH, Kirk EP, Klein S.

    Am J Clin Nutr. 2008 Aug;88(2):257-62.PMID: 18689359 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is temporarily unavailable.

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...